Redirect Notice

Looks like you clickedhttps://www.aoporphan.at/news-medien/startseite-detailseite/artikel/aop-orphan-announces-eu-marketing-authorization-for-besremiR-ropeginterferon-alfa-2b-for-rare-blood-cancer-pv.html

If you do not want to visit that page, you can close this browser tab.